Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 14, 2015; 21(42): 12083-12090
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12083
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12083
Table 1 Risk of de novo hepatitis B in recipients of anti-HBc-positive organs
| Recipient status | Naive | AntiHBc+ | AntiHBc+ | AntiHBc- |
| AntiHBs- | AntiHBs+ | AntiHBs+ | ||
| No prophylaxis | > 40% | 13% | < 2% | 10% |
| With prophylaxis | 12% | < 4% | < 2% | < 2% |
| High risk | Intermediate risk | Low risk | Intermediate risk |
- Citation: Jiménez-Pérez M, González-Grande R, Mostazo Torres J, González Arjona C, Rando-Muñoz FJ. Management of hepatitis B virus infection after liver transplantation. World J Gastroenterol 2015; 21(42): 12083-12090
- URL: https://www.wjgnet.com/1007-9327/full/v21/i42/12083.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i42.12083